Real-world outcomes in 2646 psoriasis patients: one in five has PASI ≥10 and/or DLQI ≥10 under ongoing systemic therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Real-world outcomes in 2646 psoriasis patients: one in five has PASI ≥10 and/or DLQI ≥10 under ongoing systemic therapy

Published:2017-03-02 Issue:6 Volume:28 Page:500-504
ISSN:0954-6634
Container-title:Journal of Dermatological Treatment
language:en
Short-container-title:Journal of Dermatological Treatment

Author:

Norlin J. M.¹^ORCID,Calara P. S.¹^ORCID,Persson U.¹²,Schmitt-Egenolf M.³^ORCID

Affiliation:

1. The Swedish Institute for Health Economics (IHE), Lund, Sweden;

2. Lund Institute of Economic Research, School of Economics and Management, Lund University, Lund, Sweden;

3. Department of Public Health and Clinical Medicine, Dermatology, Umeå University, Umeå, Sweden

Funder

Swedish Board of Health and Welfare

Swedish Association of Local Authorities and Regions

Västerbotten County Council

Eli Lilly

Novartis

Celgene

Publisher

Informa UK Limited

Subject

Dermatology

Link

https://www.tandfonline.com/doi/pdf/10.1080/09546634.2017.1289147

Reference39 articles.

1. Iatrogenic effects of biologics for psoriasis

2. Immunogenicity of anti-TNFα therapy in psoriasis: a clinical issue?

3. Antidrug antibodies in psoriasis: a systematic review

4. Predicting treatment response in psoriasis using serum levels of adalimumab and etanercept: a single-centre, cohort study

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real‐life experience with dimethylfumarate in palmoplantar psoriasis: A multicentre retrospective Italian study;Australasian Journal of Dermatology;2024-01-24

2. Safety, tolerability, efficacy, pharmacokinetics, and pharmacodynamics of the oral TYK2 inhibitor PF-06826647 in participants with plaque psoriasis: a phase 1, randomised, double-blind, placebo-controlled, parallel-group study;The Lancet Rheumatology;2021-03

3. Unmet needs in patients with moderate-to-severe plaque psoriasis treated with methotrexate in real world practice: FirST study;Journal of Dermatological Treatment;2020-09-08

4. Health state utility values derived from EQ-5D in psoriatic patients: a systematic review and meta-analysis;Journal of Dermatological Treatment;2020-08-09

5. The National Psoriasis Foundation psoriasis treatment targets in real‐world patients: prevalence and association with patient‐reported outcomes in the Corrona Psoriasis Registry;Journal of the European Academy of Dermatology and Venereology;2020-06-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3